<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00678964</url>
  </required_header>
  <id_info>
    <org_study_id>EudraCT 2005-005827-32</org_study_id>
    <secondary_id>ML19747</secondary_id>
    <nct_id>NCT00678964</nct_id>
  </id_info>
  <brief_title>Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)</brief_title>
  <acronym>TIE</acronym>
  <official_title>Multicentre Randomised Phase II Trial of Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients (=/&gt; 70 Years) With Advanced Non-Small Cell Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LungenClinic Grosshansdorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LungenClinic Grosshansdorf</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      60% of all malignant diseases occur in patients who are 65 years or older. For these
      patients, aggressive treatments are often not suitable due to reduced life-expectancy,
      reduced general condition, comorbidities, and reduced vital functions which can lead to
      increased adverse effects of chemotherapy. Therefore, it is important to investigate
      alternative therapy options for elderly patients.

      Erlotinib is an orally applied medication which is associated with reasonable toxicity. This
      targeted agent may prove an effective and well-tolerated first-line therapy in elderly
      patients with advanced non small cell lung cancer.

      Therefore, the aim of this study is to investigate the progression-free survival of the
      combination of vinorelbine and carboplatin in comparison to erlotinib. Given that there will
      be no significant reduction of efficiency this may provide elderly patients of more than 70
      years of age with an active oral substance without subjecting them to the sometimes severe
      adverse effect of the chemotherapy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2006</start_date>
  <primary_completion_date type="Anticipated">November 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the progression free survival rate with the first-line therapy</measure>
    <time_frame>Tumour assessment every other cycle (interval of 42 days)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of remission</measure>
    <time_frame>Tumour assessment every other cycle (interval of 42 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-year survival</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>End of study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response rate (CR/RR)</measure>
    <time_frame>Tumour assessment every other cycle (interval of 42 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life, improvement of symptoms (FACT-L)</measure>
    <time_frame>Every other cycle (interval of 42 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Simplified Charlsons´Comorbidity Score</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety and Tolerability</measure>
    <time_frame>continously</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Non-Small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Erlotinib</intervention_name>
    <description>Erlotinib 150 mg, p.o., once daily</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Tarceva</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vinorelbine and Carboplatin</intervention_name>
    <description>Vinorelbine 25 mg/m2, i.v., day 1 and 8 of every cycle (21 days) plus carboplatin AUC 5, i.v., day 1 of every cycle</description>
    <arm_group_label>B</arm_group_label>
    <other_name>Navelbine</other_name>
    <other_name>Carboplat</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically or cytological proven NSCLC, stage lll b (with pleural effusion) or
             stage lV.

          -  Tumour is locally advanced and not suitable for surgery and radiotherapy is not
             indicated.

          -  Neither cytostatic nor immunological pre-treatment

          -  Age &gt;70 years

          -  At least one measurable lesion (RECIST criteria) that was not previously irradiated

          -  ECOG Performance Status 0-1

          -  Life expectancy &gt; 3 month

          -  Adequate bone marrow function: ANC &gt; 1.5 x 109/L, Platelets &gt; 100 x 109/L

          -  Adequate liver function: Total Bilirubin &lt; 1.5 x ULN, GOT/GPT&lt; 3 x ULN (existent liver
             metastases &lt; 5 x ULN)

          -  Adequate renal function:creatinine clearance &gt; 45 ml/min (calculated according to
             Cockroft-Gault)

          -  Fertile men must agree to use an effective method of birth control while participating
             in this study

          -  Signed written informed consent

        Exclusion Criteria:

          -  Uncontrolled metastasis in the CNS

          -  Acute, heavy uncontrolled infection

          -  Any other serious concomitant disease or medical condition, which could interfere with
             participating in this study

          -  Severe hypersensitivity to Erlotinib or any other component

          -  Hypersensitivity to Carboplatin and/or other platinum compounds

          -  Hypersensitivity to Vinorelbin or other Vinca-alkaloids

          -  Patients with a history of other active malignancy in the past 5 years (with the
             exception of carcinoma in situ of the cervix, non melanomatous skin cancers or local
             prostate carcinoma that was surgically treated successfully) are excluded.

          -  Participation in another clinical trial with any investigational drug at the same time
             or within 30 days prior to registration

          -  Psychological, familial, social or geographical situations limiting the compliance
             with the study requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Reck, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>LungenClinic Grosshansdorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gemeinschaftspraxis</name>
      <address>
        <city>Augsburg</city>
        <zip>86150</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heinrich, Dr.</last_name>
      <phone>+41 821 344650</phone>
    </contact>
    <investigator>
      <last_name>Heinrich, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zentralklinik Bad Berka GmbH</name>
      <address>
        <city>Bad Berka</city>
        <zip>99437</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bonnet, Dr.</last_name>
      <phone>+41 36458 51500</phone>
    </contact>
    <investigator>
      <last_name>Bonnet, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charité - Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Schmittel, Dr.</last_name>
      <phone>+41 30 84453090</phone>
    </contact>
    <investigator>
      <last_name>Alexander Schmittel, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Emil von Behring</name>
      <address>
        <city>Berlin</city>
        <zip>14165</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Serke, Dr.</last_name>
      <phone>+41 30 80022304</phone>
    </contact>
    <investigator>
      <last_name>Monika Serke, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evangelische Lungenklinik Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylke Kurz, Dr.</last_name>
      <phone>+41 30 94802112</phone>
    </contact>
    <investigator>
      <last_name>Sylke Kurz, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evang. Krankenhaus Bielefeld</name>
      <address>
        <city>Bielefeld</city>
        <zip>33611</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meinolf Karthaus, Prof. Dr.</last_name>
      <phone>+41 521 77275504</phone>
    </contact>
    <investigator>
      <last_name>Meinolf Karthaus, Prof. dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johanniter-Krankenhaus Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53113</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yon-Dschun Ko, Prof. Dr.</last_name>
      <phone>+41 228 5432202</phone>
    </contact>
    <investigator>
      <last_name>Yon-Dschun Ko, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis</name>
      <address>
        <city>Celle</city>
        <zip>29221</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raack, Dr.</last_name>
      <phone>+41 5141 9929490</phone>
    </contact>
    <investigator>
      <last_name>Raack, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fachkrankenhaus Coswig</name>
      <address>
        <city>Coswig</city>
        <zip>01640</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerd Höffken, Prof. Dr.</last_name>
      <phone>+41 3523 65-0</phone>
    </contact>
    <investigator>
      <last_name>Gerd Höffken, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fachklinik Diekholzen</name>
      <address>
        <city>Diekholzen</city>
        <zip>31199</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfram Meister, Dr.</last_name>
      <phone>+41 5121 201383</phone>
    </contact>
    <investigator>
      <last_name>Wolfram Meister, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Donaustauf</name>
      <address>
        <city>Donaustauf</city>
        <zip>93093</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Meidenbauer, Dr.</last_name>
      <phone>+41 9403 800</phone>
    </contact>
    <investigator>
      <last_name>Norbert Meidenbauer, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Katholisches Klinikum Duisburg</name>
      <address>
        <city>Duisburg</city>
        <zip>47166</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Schroeder, Dr.</last_name>
      <phone>+41 203 5462482</phone>
    </contact>
    <investigator>
      <last_name>Michael Schroeder, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marien Hospital Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40479</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Schütte, Prof. Dr.</last_name>
      <phone>+41 211 44002501</phone>
    </contact>
    <investigator>
      <last_name>Schütte, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Essen</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eberhardt, Dr.</last_name>
      <phone>+41 201 723-2168</phone>
    </contact>
    <investigator>
      <last_name>Eberhardt, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Essen-Mitte</name>
      <address>
        <city>Essen</city>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koester, Prof. Dr.</last_name>
      <phone>+41 201 1741251</phone>
    </contact>
    <investigator>
      <last_name>Koester, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Nordwest GmbH</name>
      <address>
        <city>Frankfurt/Main</city>
        <zip>60488</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elke Jäger, Prof. Dr.</last_name>
      <phone>+41 69 76013340</phone>
    </contact>
    <investigator>
      <last_name>Elke Jäger, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asklepios Fachkliniken München-Gauting</name>
      <address>
        <city>Gauting</city>
        <zip>82131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>von Pawel, Dr.</last_name>
      <phone>+41 89 857912011</phone>
    </contact>
    <investigator>
      <last_name>von Pawel, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schwerpunktpraxis Onkologie</name>
      <address>
        <city>Goslar</city>
        <zip>38642</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tessen, Dr.</last_name>
      <phone>+41 5321 686102</phone>
    </contact>
    <investigator>
      <last_name>Tessen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum der Ernst-Moritz Arndt Universität Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf Ewert, Prof. Dr.</last_name>
      <phone>+41 3834 866776</phone>
    </contact>
    <investigator>
      <last_name>Ralf Ewert, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Großhansdorf</name>
      <address>
        <city>Großhansdorf</city>
        <zip>22927</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Reck, Dr.</last_name>
      <phone>+41 4102 601188</phone>
    </contact>
    <investigator>
      <last_name>Martin Reck, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georg-August-Universität Göttingen</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Schüttrumpf, Dr.</last_name>
      <phone>+41 551 398538</phone>
    </contact>
    <investigator>
      <last_name>Schüttrumpf, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Harburg</name>
      <address>
        <city>Hamburg</city>
        <zip>21075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaukel, Prof. Dr.</last_name>
      <phone>+41 40 1818860</phone>
    </contact>
    <investigator>
      <last_name>Kaukel, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Dickgreber, Dr.</last_name>
      <phone>+41 511 5323934</phone>
    </contact>
    <investigator>
      <last_name>Nicolas Dickgreber, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thoraxklinik am Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Thomas, Prof. Dr.</last_name>
      <phone>+41 6221 3961300</phone>
    </contact>
    <investigator>
      <last_name>Michael Thomas, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lungenklinik Hemer</name>
      <address>
        <city>Hemer</city>
        <zip>58675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lutz Freitag, Dr.</last_name>
      <phone>+41 2372 9082201</phone>
    </contact>
    <investigator>
      <last_name>Lutz Freitag, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik des Saarlandes</name>
      <address>
        <city>Homburg/Saar</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Göschel, Dr.</last_name>
      <phone>+41 8641 1623614</phone>
    </contact>
    <investigator>
      <last_name>Andreas Göschel, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Friedrich-Schiller-Universität</name>
      <address>
        <city>Jena</city>
        <zip>07740</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelika Reißig, Dr.</last_name>
      <phone>+41 3641 9329131</phone>
    </contact>
    <investigator>
      <last_name>Angelika Reißig, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Kassel</name>
      <address>
        <city>Kassel</city>
        <zip>34125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Wolf, Prof. Dr.</last_name>
      <phone>+41 561 9803045</phone>
    </contact>
    <investigator>
      <last_name>Martin Wolf, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Malteser Krankenhaus St. Hildegardis Köln</name>
      <address>
        <city>Köln</city>
        <zip>50931</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael von Eiff, Prof. Dr.</last_name>
      <phone>+41 221 4003231</phone>
    </contact>
    <investigator>
      <last_name>Michael von Eiff, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Leverkusen gGmbH</name>
      <address>
        <city>Leverkusen</city>
        <zip>51375</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Niederle, Prof. Dr.</last_name>
      <phone>+41 214 132672</phone>
    </contact>
    <investigator>
      <last_name>Niederle, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik Löwenstein gGmbH</name>
      <address>
        <city>Loewenstein</city>
        <zip>74245</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fischer, Dr.</last_name>
      <phone>+41 7130 15-0</phone>
    </contact>
    <investigator>
      <last_name>Fischer, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Lübeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dalhoff, Prof. Dr.</last_name>
      <phone>+41 451 5002375</phone>
    </contact>
    <investigator>
      <last_name>Dalhoff, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Katholisches Klinikum Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kortsik, Prof. Dr.</last_name>
      <phone>+41 6131 147412</phone>
    </contact>
    <investigator>
      <last_name>Kortsik, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Johannes Gutenberg-Universität Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fischer, Dr.</last_name>
      <phone>+41 6131 177135</phone>
    </contact>
    <investigator>
      <last_name>Fischer, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Mannheim gGmbH</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dieter Buchheidt, Dr.</last_name>
      <phone>+41 621 3834110</phone>
    </contact>
    <investigator>
      <last_name>Dieter Buchheidt, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zweckverband Kliniken im Mühlenkreis</name>
      <address>
        <city>Minden</city>
        <zip>32423</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bodenstein, Prof. Dr.</last_name>
      <phone>+41 571 801-4810</phone>
    </contact>
    <investigator>
      <last_name>Bodenstein, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Klinik - Innenstadt</name>
      <address>
        <city>München</city>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huber, Prof. Dr.</last_name>
      <phone>+41 89 51602590</phone>
    </contact>
    <investigator>
      <last_name>Huber, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ruppiner Kliniken GmbH</name>
      <address>
        <city>Neuruppin</city>
        <zip>16816</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deppermann, Dr.</last_name>
      <phone>+49 3391 393112</phone>
    </contact>
    <investigator>
      <last_name>Deppermann, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johanniter-Krankenhaus im Fläming gGmbH</name>
      <address>
        <city>Treuenbrietzen</city>
        <zip>14929</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steffi Mai, Dr.</last_name>
      <phone>+41 33748 82441</phone>
    </contact>
    <investigator>
      <last_name>Steffi Mai, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Schumann, Dr.</last_name>
      <phone>+41 731 50024453</phone>
    </contact>
    <investigator>
      <last_name>Stefan Krüger, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2008</study_first_submitted>
  <study_first_submitted_qc>May 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2008</study_first_posted>
  <last_update_submitted>May 15, 2008</last_update_submitted>
  <last_update_submitted_qc>May 15, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Martin Reck</name_title>
    <organization>Hospital Grosshansdorf</organization>
  </responsible_party>
  <keyword>NSCLC</keyword>
  <keyword>Elderly patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vinorelbine</mesh_term>
    <mesh_term>Carboplatin</mesh_term>
    <mesh_term>Erlotinib Hydrochloride</mesh_term>
    <mesh_term>Vinblastine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

